CELEBRATING 24 YEARS IN BUSINESS OVER 300,000 CLIENTS REPRESENTED
Januvia, a drug approved in 2006 by the FDA to be used in the treatment of Type 2 diabetes, has been found to bring a risk of pancreatitis, pancreatic cancer and thyroid cancer among users. Reports of 88 serious cases of pancreatitis were sent to the FDA between the time Januvia was approved and 2009. Of these 88 cases, over half resolved when Januvia was discontinued. At least one-fifth of the patients had only been taking Januvia for a month or less and 75% of the patients required hospitalization.
WARNING: Do not send any information in any email through this website if you consider the information confidential or privileged.
STARS ON YELP WITH OVER 400 REVIEWS*
*AS OF 2024
TOP 10 VERDICT IN TEXAS* 2022
*BY TOPVERDICT.COM
TOP 100 NATIONAL TRIAL LAWYER* 2013-2025
*BY THE NATIONAL TRIAL LAWYERS
AVVO CLIENT'S CHOICE AWARD* 2016, 2017, 2019-2024
*GIVEN BY AVVO
AMERICAN ASSOCIATION OF JUSTICE 2013-2024
*GRANTED BY THE AAJ